CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing consumption of alcohol and tobacco
4.1.2. Growing awareness about thyroid disorders
4.1.3. Increasing incidence of thyroid disorders
4.1.4. Rising prevalence of lifestyle diseases and rising geriatric population
4.2. Market Restraints & Challenges
4.2.1. Fluctuations in the reference range for thyroid function tests
4.2.2. Unfavourable healthcare reforms in the US
4.3. Market Opportunities
4.3.1. Growth opportunities in emerging Asia Pacific countries
4.3.2. Increasing awareness among the patients
CHAPTER 5. GLOBAL THYROID FUNCTION TEST MARKET – BY TYPE
5.1. Introduction
5.2. T3 Tests
5.3. T4 Tests
5.4. TSH Tests
5.5. Other Tests
CHAPTER 6. GLOBAL THYROID FUNCTION TEST MARKET – BY END USER
6.1. Introduction
6.2. Hospitals
6.3. Diagnostic laboratories
6.4. Research laboratories and institutes
6.5. Other end users
CHAPTER 7. GLOBAL THYROID FUNCTION TEST MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL THYROID FUNCTION TEST MARKET - COMPANY
PROFILES
8.1. Beckman Coulter Inc.
8.2. Siemens healthcare diagnostics
8.3. Abbott Laboratories.
8.4. Sigma-Aldrich Co.
8.5. bioMérieux
8.6. DiaSorin.
8.7. IMMUNO-BIOLOGICAL LABORATORIES INC.
8.8. Pfizer Inc.
8.9. Novartis International AG.
8.10. Roche Holding AG.
8.11. Diagnostic Automation.
8.12. Qualigen Inc.
8.13. Twine Health, Inc.
8.14. Well Doc Inc.
8.15. KRONUS Inc.
CHAPTER 9. GLOBAL THYROID FUNCTION TEST MARKET - COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
